London Stock Exchange welcomes Kanabo Group PLC to the Main Market

London Stock Exchange today welcomes Kanabo Group Plc (“Kanabo” or the “Company”) to trading on the Main Market. Kanabo (LSE: KNB) successfully completed an IPO of £6 million that was oversubscribed, giving it a market capitalisation of approximately £23.4 million on admission. 

Kanabo aims to create a new standard in the medical cannabis industry by building an ecosystem that improves the well-being of millions around the world by providing an alternative solution to the smoking of medicinal cannabis flowers. With a focus on the distribution of cannabis-derived products for medical patients, and non-THC products for CBD consumers, Kanabo has conducted extensive Research & Development in order to produce high-quality cannabis extract formulas, innovative medical-grade vaporisers, and various non-smoking consumption solutions – making use easy and accessible for anyone in need of treatment.

The formulas have been designed specifically for use with the VapePod®, Kanabo's cutting-edge cannabis oil vaporisation device that provides metered doses, allowing extremely accurate consumption. The VapePod is the first-ever medically certified vaporisation delivery system for cannabis extracts and is expected to be registered as a CE Medical Device in the European Union. 

The company is currently selling initial products in the UK and Germany and is ready to scale up to meet market demands and projected sales and revenues. Given it is in advanced stages to receive the EU-registered CE mark, Kanabo is already in talks with several distributors who have taken an interest in partnering in the EU. Future products in development are on the horizon for the next year, particularly the second generation medically certified device, new medicinal cannabis oils, and clinical trials. 

Kanabo’s goal is to lead the emerging markets of medical cannabis in the medical vaporisation category, providing a healthy alternative for many of the patients who are smoking cannabis today. Kanabo is committed to a high standard, having a certified medical device and an EU-GMP production, and has built great partnerships and will continue to build more.

Avihu Tamir, founder and CEO commented: “It’s an honour to be the first cannabis company to list by way of RTO on London Stock Exchange. Listed public cannabis companies are a “game changer” for the cannabis industry, which is predicted to be worth over €2 billion in Europe in the next four years. We are excited that the Medical Cannabis industry is set to take off in the UK and Europe, similar to the way it has in North America in recent years”

David Tsur, Company Chairman added: “We are proud of the support and confidence of the investors that joined our IPO. We have seen a big oversubscribed round, and we will be able to execute our milestones and bring significant value to the market.”

Quick facts

Market: Main Market
Instrument market cap (£m)
Listing/Admission to trading
17 May 2017
Looking for new and recent issues?

More recent

London Stock Exchange welcomes The Arab Federation of Capital Markets.

  General Overview 

The Arab Federation of Capital Markets (AFCM) is the Arab industry group for Exchanges and Clearing houses, and Financial Institutions around the Arab regions. It was established in 1978 to be the guiding body for the Arab Stock Exchanges, under the recommendation of the Arab Central Ban

Learn more
London Stock Exchange welcomes EnSilica plc to AIM

EnSilica is a designer and supplier of mixed signal ASICs (Application Specific Integrated Circuit). ASICs are Integrated Circuits or semiconductor chips developed for a particular use or product rather than for general purpose usage.  ASICs help differentiate products through optimised hardware making products smaller, faster, lower power, improved security, add

Learn more
London Stock Exchange Group welcomes The Future Investment Initiative Institute, celebrating the launch of the FII regional summit “Inclusive ESG for Emerging Markets”

The Future Investment Initiative (FII) Institute is a new global nonprofit foundation with an investment arm and one agenda: Impact on Humanity. Global, inclusive and committed to ESG principles, the FII Institute fosters great minds from around the world and turn ideas into real-world solutions in four critical areas: AI and Robotics, Education, Healthcare and Sustainability. The FII Institute

Learn more
European Assets Trust PLC celebrates 50 years.

This year, European Assets Trust PLC celebrates its fiftieth anniversary since launch in May 1972. The Company was created in 1972 following the acquisition of a Dutch investment company ‘Mijbeb NV’ by a consortium of United Kingdom institutional investors and the appointment of a predecessor of BMO Investment Business Limited as its Manager.

Initially the Company was listed solely on

Learn more